Updated 06:01 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,040.30 -0.28% CL 101.33 -1.41% BTC 80,120.34 -0.85%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,040 −0.28% BTC $80,120 −0.85% VIX 16.91 −3.48% latest tape · as of 06:01 UTC
The Screen · Consumer Cyclical

Caleres, Inc.

CAL · the NYSE · USD · Market cap $473M

FAIL · Does not pass the screen
12.96 USD

Price as of 28 Oct 2026Daily close, not a live quote

Screened 2026-10-28 · the tape above runs as of 06:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price12.96 USD at the 28 Oct 2026 close
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 2.10)
  • Last reviewed28 Oct 2026 (1 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
22.7924.9225.92

What this means: price 12.96 against the desk's fair-value range, base estimate 24.92, over the last year.

Current read
Accumulation ?
Screened · screened 2026-10-28
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 2.10, read 2026-10-25
  • Ethical does not pass the values gate
Price12.96 USD
Fair value24.92
Ethical score70.0/100
Our investment reviews on this name
2026-10-20Read Accumulation13.14-1.4% to today Markdown gives way to Accumulation after a 9% rise in 7 days
2026-10-13Read Markdown12.09+7.2% to today Accumulation gives way to Markdown
2026-10-02Read Accumulation11.91+8.8% to today ✓Markup gives way to Accumulation
2026-07-02Read Markup12.37+4.8% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Caleres, Inc. holds its Accumulation at $12.96. The statistical read favours the sellers, held for 39 days.

As held on the ledger · 2026-10-28
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 39 days
Price at the screen$12.96
ValuationN/A trailing · 5.52 forward price to earnings
Values screenFAIL · score 70.0
Beta0.72
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 183.67% Below 33% Interest-bearing debt is 183.7% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 6.14% Below 33% Cash held in interest-bearing accounts and securities is 6.1% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Caleres,'s business is in a permissible area, but its interest-bearing debt is about 184% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CAL's ethical verdict changes

Today CAL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

22.79Conservative24.92Base case25.92Growth case 12.96Price

Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 92.3% margin of safety to the base estimate.

Price History & Projections
$33.6$20.6$7.6TODAY5y agoPROJECTIONOur fair value$24.92 +83%Conservative$22.79 +67%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E5.5xcheap for a company growing this fast
EPS, trailing-0.21
EPS, forward2.16
Revenue growth+8.7%steady growth
Profit margin-0.2%currently unprofitable
Return on equity-1.6%not currently earning a positive return on equity
Dividend yield195.00%
Debt to equity1.46a meaningful debt load worth watching
Beta0.72steadier than the market
MoatWEAK
Market cap$473M

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CAL trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-27 Accumulation $13.14 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-20 Accumulation · changed $13.14 +8.7% Entry 8

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 5% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-13 Markdown · changed $12.09 +1.5% Entry 7

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-02 Accumulation · changed $11.91 -3.7% Entry 6

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-08-24 Markup $12.37 +0.0% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-07-24 Markup $12.37 +0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-07-18 Markup $12.37 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-07-03 Markup $12.37 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Markup $12.37 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Political Ledger · Congressional Disclosures
Disclosures naming CAL
DatePoliticianPartyTypeAmount
2026-09-29 Gil Cisneros Democrat buy 1K–15K
2026-09-29 Gil Cisneros Democrat buy 1K–15K
2026-09-25 Ro Khanna Democrat buy 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $12.06 +13.0% · $1,130 +13.0%
2 months $12.52 +8.9% · $1,089 +8.9%
3 months $9.35 +45.8% $0.07 $1,465 +46.5%
6 months $13.37 +1.9% $0.14 $1,030 +3.0%
1 year $14.10 -3.3% $0.21 $982 -1.8%
2 years $31.83 -57.2% $0.49 $444 -55.6%
3 years $22.91 -40.5% $0.77 $629 -37.1%
5 years $26.17 -47.9% $1.33 $572 -42.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CAL does next, these words stay.

Caleres, Inc. · CAL · Accumulation · $12.96
Recorded 2026-10-28 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.